Cardioankle Vascular Index Evaluations Revealed That Cotreatment of ARB Antihypertension Medication With Traditional Chinese Medicine Improved Arterial Functionality
Authors:
- Yan XuYXYan Xu
- Hua YanHYHua Yan
- Min J. YaoMYMin J. Yao
- Jie MaJMJie Ma
- Jun M. JiaJJJun M. Jia
- Fen X. RuanFRFen X. Ruan
- Zeng C. YaoZYZeng C. Yao
- Hua M. HuangHHHua M. Huang
- Jing ZhengJZJing Zheng
- Ting ChenTCTing Chen
- Hua LvHLHua Lv
- Alexander M. EndlerAEAlexander M. Endler
- 1 May 2013
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Cardiovascular Pharmacology
- Vol. 61 (5) , 355-360
Abstract
Qian Yang He Ji (QYHJ) is a traditional Chinese medicine composed of Digitalis purpurea, Uncaria gambir, Fructus tribuli terrestris, and Ligustrum lucidum. Here, we explored whether combining an antihypertensive angiotensin II receptor blocker (ARB) therapy with QYHJ can improve the arterial functionality of hypertensive patients. One hundred and eight hypertensive patients were randomized into 2 groups; 1 group (n = 53) was treated with ARB and the other group (n = 55) was treated with ARB combined with QYHJ. Each of the 2 groups included 3 subgroups (pure hypertension, hypertension with diabetes, and hypertension with coronary heart disease) and was further divided into patients with and without complications. The cardioankle vascular index and intima-media thickness and pulse pressure were the outcome evaluation parameter. Combined QYHJ and ARB treatment reduced the values of cardioankle vascular index, systolic blood pressure, diastolic blood pressure, and pulse pressure to significantly lower levels than ARB treatment alone did in hypertension patients after 6 months of treatment. ARB improves hypertension, but a combined QYHJ treatment can additionally ameliorate the arterial functionality not only in solely hypertensive patients but also in hypertensive patients with diabetes and coronary heart disease complications. QYHJ coapplication might be a choice to further improve the arterial functionality during an ARB hypertension treatment.Keywords
This publication has 23 references indexed in Scilit:
- Effects of individual risk factors on the residual risk of cardiovascular events in a population of treated Chinese patients with hypertension: data from the Felodipine Event Reduction (FEVER) studyJournal Of Hypertension, 2010
- Effects of Olmesartan, an Angiotensin II Receptor Blocker, and Amlodipine, a Calcium Channel Blocker, on Cardio-Ankle Vascular Index (CAVI) in Type 2 Diabetic Patients with HypertensionJournal of Atherosclerosis and Thrombosis, 2009
- Contrôle tensionnel, facteurs de risque et pronostic cardiovasculaire du patient diabétique: 30 ans de progrèsJournal Of Hypertension, 2008
- Cardio-Ankle Vascular Index is a New Noninvasive Parameter of Arterial StiffnessCirculation Journal, 2007
- Hypertension in the intensive care unitCurrent Opinion in Cardiology, 2006
- Changes in Aortic Stiffness and Augmentation Index After Acute Converting Enzyme or Vasopeptidase InhibitionHypertension, 2005
- Cardio-ankle vascular index (CAVI) for the monitoring of the atherosclerosis after heart transplantationBiomedicine & Pharmacotherapy, 2005
- Influence of pretreatment systolic blood pressure on the effect of carvedilol in patients with severe chronic heart failureJACC, 2004
- Sinitang (Shigyaku-to), a traditional Chinese medicine improves microcirculatory disturbances induced by endotoxin in ratsJournal of Ethnopharmacology, 1999
- Therapeutic Effects of Nitric Oxide-Donor Isosorbide Dinitrate on Atherosclerosis-Induced Alterations in Hemodynamics and Arterial Viscoelasticity Are Independent of the Wall Elastic ComponentJournal of Cardiovascular Pharmacology, 1996